1,173 New COVID-19 Cases Since Monday’s Report

    & 11 Deaths Reported

47,224 Total Positive Cases & 1,102 Total Deaths

MOHAVE COUNTY, AZ (January 27, 2022) — The Mohave County Health Department (MCDPH) Nursing staff has been notified of 1,173 new confirmed COVID-19 cases reported today. There are also 11 newly reported deaths. Ten of the deaths are from previously reported positive cases. The 11^th death is also one of today’s new positive cases.

Seven of the deaths are from the Bullhead City service area. Five are 70-79; one is 80-89; one is 90+.

One case is a 60-69 person from the Kingman service area.

Three cases are from the Lake Havasu City service area. Two are 70-79.  The other case is also one of the new positive cases reported today, an 80-89 person.

ALL 1,173 new confirmed positive cases remain under investigation.

Of the 1,173 new confirmed cases, there are 525 confirmed cases in the Bullhead City service area. There are 460 new confirmed cases in the Kingman service area. There are 173 new confirmed cases in the Lake Havasu City service area. There are 14 new confirmed cases in the North County service area.  There are 11 new confirmed cases in an Undetermined or Unknown area of the county.

Of the 515 new confirmed cases in the Bullhead City area, 40 are 0-10; 40 are 11-19; 58 are 20-29; 74 are 30-39; 59 are 40-49; 77 are 50-59; 86 are 60-69; 57 are 70-79; 22 are 80-89; 2 are 90+.

Of the 460 new confirmed cases in the Kingman area, 44 are 0-10; 58 are 11-19; 50 are 20-29; 67 are 30-39; 60 are 40-49; 69 are 50-59; 65 are 60-69; 40 are 70-79; 5 are 80-89; 2 are 90+.

Of the 173 new confirmed cases in the Lake Havasu City area, 11 are 0-10; 10 are 11-19; 21 are 20-29; 21 are 30-39; 17 are 40-49; 29 are 50-59; 24 are 60-69; 33 are 70-79; 4 are 80-89 and one of those is also one of today’s new positive cases; 3 are 90+.

Of the 14 new confirmed cases in the North County area, 3 are 11-19; 3 are 20-29; 1 is 30-39; 1 is 40-49; 2 are 50-59; 2 are 60-69. 2 are 80-89.

Of the 11 new confirmed cases in an Unknown/Undermined area of the county, 1 is 11-19; 1 is 30-39; 1 is 40-49; 2 are 50-59; 4 are 60-69; 1 is 70-79; 1 is 80-89.

TOTAL RECOVERED THUS FAR: 34,592

AVERAGE AGE OF CASES SINCE CASE #1: 44.6

AVERAGE AGE OF DEATHS SINCE FIRST DEATH: 72.1

In the United States, CDC uses genomic surveillance to track variants of SARS-CoV-2, the virus that causes COVID-19, to more quickly identify and act upon these findings to best protect the public’s health. CDC reports that if a variant is circulating at 0.1% frequency, there is a 99% chance it will be detected in CDC’s national genomic surveillance.

CDC scientists will continue working with partners to gather data and virus samples that can be studied to answer essential questions and inform pubic health practice regarding the Omicron variant as it spreads in the  U.S. and other parts of the world.

The Omicron variant likely will spread more easily than the original SARS-CoV-2 virus. CDC expects that anyone with Omicron infection can spread the virus to others, even if they are vaccinated or don’t have symptoms. More data is needed to know if Omicron infections, reinfections, and breakthrough infections in fully vaccinated people cause more severe illness or death than infection with other variants. The CDC says COVID-19 vaccines remain the best public health measure to protect people from severe illness, slow transmission of the virus, and reduce the likelihood of new variants emerging.

Protect yourself and others

• Get Vaccinated
• Wear a mask in areas of substantial or high transmission
• Stay 6 feet away from others
• Avoid crowds and poorly ventilated spaces
• Wash your hands often
• Clean and disinfect high touch surfaces
• Cover coughs and sneezes
• Test to prevent the spread to others
• Monitor your health daily – Be alert for symptoms

 For more detailed information, please visit https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html

Treatment Options

ADHS has launched a new website for treatments in Arizona to complement the current monoclonal antibodies website.

ADHS – Everyone – Monoclonal Antibodies (mAbs) (azdhs.gov)

ADHS – Everyone – Find Treatment (azdhs.gov)

ADHS – Everyone – Antivirals (azdhs.gov)

While vaccines provide the best protection from COVID-19, treatment options such as Monoclonal Antibody therapy can shorten the duration of symptoms and reduce the risk of severe illness and hospitalization.

Monoclonal antibodies, or mAbs, are made in a laboratory to fight a particular infection — in this case, the virus that causes COVID-19 — and are given to patients directly with an infusion or a shot. Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus-like the virus that causes COVID-19. That’s why mAb treatment may help patients at high risk for severe symptoms or hospitalization.

The Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) to allow the use of monoclonal antibody therapies for the treatment of mild to moderate COVID19 in certain high-risk patients. Some people who have been exposed to COVID-19 may qualify for treatment even before testing positive for COVID-19. This treatment is not a substitute for vaccination against COVID-19.

General eligibility information is below.

• Individuals who have tested positive for COVID-19 and are within ten days of onset
• Unvaccinated individuals who have had close contact with a COVID positive person
• Vaccinated individuals who are immunocompromised and have had close contact with a COVID-positive person
• Each facility has its standards for administering Monoclonal Antibody Therapy. Please visit their respective websites or call the number provided below for more information.

Kingman Regional Medical Center (KRMC)

Website:

Seeking Medical Care For Covid-19 | KRMC | Kingman Regional Medical Center (azkrmc.com)

Phone Number: 928-681-8699

Western Arizona Regional Medical Center (WARMC)

Website: https://www.warmc.com/covid-19

Phone number: 928-763- 2273

Havasu Urgent Care (aka Havasu Primary Care and Pediatrics)

Phone number: 928-505-1030

Veklury® (Remdesivir) (FDA approved)

Veklury® (Remdesivir) works by slowing the replication of the COVID-19 virus, thereby reducing the amount of virus circulating in the body. Veklury® (Remdesivir) is approved for hospitalized patients age 12 years and older who weigh at least 88 pounds, with more severe COVID-19 disease. Your hospital care team will decide if you are eligible to receive this treatment.

Additional COVID-19 Questions?, Please Call 928-753-8665

This brought to you by